Physician profile
Gregory A Redish
NPI 1194710970
$3,120.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $759 · 2021: $533 · 2022: $150 · 2023: $79.30 · 2024: $40.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,257.45 | 2019-2024 | Confirm Rx, Aveir |
| Boston Scientific Corporation | $387.28 | 2019-2021 | |
| Amarin Pharma, INC. | $356.45 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $291.80 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $247.65 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $107.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $104.02 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $103.67 | 2019 | |
| Amgen INC. | $69.73 | 2019-2021 | |
| Pfizer INC. | $51.10 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $39.92 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.23 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.98 | 2019 | |
| Siemens Medical Solutions USA, INC. | $20.41 | 2019 | |
| Bardy Diagnostics, INC. | $15.58 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Redish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.